352 related articles for article (PubMed ID: 33116747)
1. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
2. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
3. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
[TBL] [Abstract][Full Text] [Related]
4. A systematic review on the effects of
Aucoin M; Cardozo V; McLaren MD; Garber A; Remy D; Baker J; Gratton A; Kala MA; Monteiro S; Warder C; Perciballi A; Cooley K
Metabol Open; 2021 Sep; 11():100115. PubMed ID: 34341776
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 infection: an overview on cytokine storm and related interventions.
Montazersaheb S; Hosseiniyan Khatibi SM; Hejazi MS; Tarhriz V; Farjami A; Ghasemian Sorbeni F; Farahzadi R; Ghasemnejad T
Virol J; 2022 May; 19(1):92. PubMed ID: 35619180
[TBL] [Abstract][Full Text] [Related]
6. Influence of SARS-COV-2 Infection on Cytokine Production by Mitogen-Stimulated Peripheral Blood Mononuclear Cells and Neutrophils in COVID-19 Intensive Care Unit Patients.
Essa S; Shamsah M; Alsarraf AH; Esmaeil A; Al-Shammasi A; Raghupathy R
Microorganisms; 2022 Nov; 10(11):. PubMed ID: 36363785
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection.
Mallis P; Michalopoulos E; Chatzistamatiou T; Stavropoulos-Giokas C
World J Stem Cells; 2020 Aug; 12(8):731-751. PubMed ID: 32952855
[TBL] [Abstract][Full Text] [Related]
8. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
Leija-Martínez JJ; Huang F; Del-Río-Navarro BE; Sanchéz-Muñoz F; Muñoz-Hernández O; Giacoman-Martínez A; Hall-Mondragon MS; Espinosa-Velazquez D
Med Hypotheses; 2020 Nov; 144():109935. PubMed ID: 32795834
[TBL] [Abstract][Full Text] [Related]
9. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.
Burgos-Blasco B; Güemes-Villahoz N; Santiago JL; Fernandez-Vigo JI; Espino-Paisán L; Sarriá B; García-Feijoo J; Martinez-de-la-Casa JM
Exp Eye Res; 2020 Nov; 200():108253. PubMed ID: 32949577
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet-A light reduces cellular cytokine release from human endotracheal cells infected with Coronavirus.
Leite G; Pimentel M; Mathur R; Barlow GM; Chan Y; Melmed GY; Rezaie A
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102457. PubMed ID: 34314863
[TBL] [Abstract][Full Text] [Related]
11. Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning.
Gantla MR; Tsigelny IF; Kouznetsova VL
Med Drug Discov; 2023 Feb; 17():100148. PubMed ID: 36466363
[TBL] [Abstract][Full Text] [Related]
12. Fighting the storm: could novel anti-TNFα and anti-IL-6
Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
[TBL] [Abstract][Full Text] [Related]
13. Effect of antiviral and immunomodulatory treatment on a cytokine profile in patients with COVID-19.
Martonik D; Parfieniuk-Kowerda A; Starosz A; Grubczak K; Moniuszko M; Flisiak R
Front Immunol; 2023; 14():1222170. PubMed ID: 37483627
[TBL] [Abstract][Full Text] [Related]
14. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.
Patel S; Saxena B; Mehta P
Heliyon; 2021 Feb; 7(2):e06158. PubMed ID: 33553708
[TBL] [Abstract][Full Text] [Related]
15. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.
Peter AE; Sandeep BV; Rao BG; Kalpana VL
Front Pharmacol; 2020; 11():583777. PubMed ID: 33708109
[TBL] [Abstract][Full Text] [Related]
16. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.
Kalinina O; Golovkin A; Zaikova E; Aquino A; Bezrukikh V; Melnik O; Vasilieva E; Karonova T; Kudryavtsev I; Shlyakhto E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012146
[TBL] [Abstract][Full Text] [Related]
17. The Role of Th17 Response in COVID-19.
Martonik D; Parfieniuk-Kowerda A; Rogalska M; Flisiak R
Cells; 2021 Jun; 10(6):. PubMed ID: 34205262
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.
Singh S; Barr H; Liu YC; Robins A; Heeb S; Williams P; Fogarty A; Cámara M; Martínez-Pomares L
PLoS One; 2015; 10(2):e0117447. PubMed ID: 25706389
[TBL] [Abstract][Full Text] [Related]
19. How COVID-19 induces cytokine storm with high mortality.
Hojyo S; Uchida M; Tanaka K; Hasebe R; Tanaka Y; Murakami M; Hirano T
Inflamm Regen; 2020; 40():37. PubMed ID: 33014208
[TBL] [Abstract][Full Text] [Related]
20. The first case of hemorrhagic shock and encephalopathy syndrome with fulminant hypercytokinemia associated with pediatric COVID-19.
Kurane K; Wakae K; Yamagishi H; Kawahara Y; Ono M; Tamura D; Furuya K; Taga N; Matsuki M; Yamagata T; Muramatsu K
Brain Dev; 2024 Jan; 46(1):44-48. PubMed ID: 37730452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
